Senior Director, Global Managed Access Programs, Strategy & Operations

Neurocrine Biosciences, Inc.; Allschwil; On-site; CHF 148,000 - 198,000; Full time

Job summary

Neurocrine Biosciences, Inc. seeks a Senior Director, Global Managed Access Programs, Strategy & Operations to lead the development and execution of global MAP strategies enabling access to Neurocrine medicines where traditional commercial access is not yet available or planned.

The role requires deep expertise in regulatory, operational, supply and access considerations, coordinating with Medical Affairs, Lifecycle Management, Market Access, and other partners to design scalable, compliant

Responsibilities

• Develop and lead Neurocrine's global MAP strategy and operating model for commercial and development-stage assets across asset lifecycle and geography.
• Establish scalable processes, governance, and operations tailored to each asset, patient population, geography and development stage.
• Collaborate with Medical Affairs, Lifecycle Management, Commercial, Market Access, Regulatory and other functions to determine MAP fit, objectives, scope and timing.
• Prioritize countries/regions and assess feasibility considering unmet need, regulatory pathways, demand, availability, launch plans, pricing and supply.
• Incorporate MAP planning into asset lifecycle and launch planning beyond reacting to individual patient requests.
• Develop strategies to meet immediate patient needs while maintaining flexibility for approvals, reimbursement and footprint changes.

Job description

Who We Are:

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life‑changing treatments for patients with under‑addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA‑approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader‑Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid‑to late‑phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)

At Neurocrine, strong leadership drives both business results and team success. We look for leaders who think strategically, anticipate what's ahead and set clear direction, while building and empowering high‑performing teams. Successful leaders foster an environment where people are motivated to do their best work and deliver meaningful, measurable impact through sound decision‑making and accountability.

About the Role:

The Senior Director, Global Managed Access Programs, Strategy & Operations will provide strategic and operational leadership for the development and execution of Neurocrine's global Managed Access Programs (MAP) (eg, early access, post‑trial access, name patient sales, etc.), enabling appropriate access to Neurocrine medicines for patients in countries where traditional commercial access is not yet available or is not planned.

This individual will serve as the enterprise leader for managed access strategy and execution, bringing together Medical Affairs, Lifecycle Management, Market Access, Commercial, Regulatory Affairs, Pharmacovigilance, Quality, Technical Operations/Supply Chain, Legal, Compliance, Finance and other partners to determine where and how MAP should be implemented across the Neurocrine portfolio.

The Senior Director will be accountable for translating asset and lifecycle strategy into scalable, compliant and operationally executable access pathways across countries. The Senior Director will support managed access planning across the product lifecycle (eg, Early/Expanded Access Programs, Single/Named Patient Access, cohort programs, Post‑Trial Access, and other pre‑and post‑approval access pathways, as appropriate). The role will lead the selection, oversight and governance of external partners responsible for program administration, regulatory coordination, distribution and other access services, while ensuring Neurocrine maintains appropriate strategic oversight, decision‑making and accountability.

This role requires deep expertise in the complex regulatory, operational, supply and access considerations associated with providing medicines outside traditional commercial channels. The successful candidate will combine strategic thinking with strong operational leadership and will be able to navigate highly matrixed, time‑sensitive situations where patient need, regulatory requirements, supply considerations and long‑term asset strategy intersect.

Your Contributions (include, but are not limited to):

Global Managed Access Program Strategy

• Develop and lead Neurocrine's global strategy and operating model for MAP across commercial and development‑stage assets, in alignment with overall asset, lifecycle and geographic expansion strategies


• Establish scalable processes, governance, and operational capabilities while recognizing that managed access strategies should be tailored to the specific needs of each asset, patient population, geography and stage of development


• Partner with Medical Affairs, Lifecycle Management, Commercial, Market Access, Regulatory and other functions to assess when an MAP is appropriate and define the objectives, geographic scope, timing, eligibility framework and operating model for each program


• Lead country and regional prioritization and feasibility assessments, considering unmet medical need, regulatory pathways, anticipated patient demand, local treatment availability, commercial launch plans, pricing and reimbursement timelines, supply requirements and operational complexity


• Ensure MAP planning is incorporated proactively into asset lifecycle and launch planning rather than managed solely in response to individual patient requests


• Develop strategies that allow Neurocrine to responsibly address immediate patient need while preserving flexibility as regulatory approval, reimbursement, commercial footprint